In Th17 cells from patients with RA, IL-9 stimulation of PBMCs and SF samples increased the proportion of CD4+IL-17A+ and RORγt+ T cells, whereas anti-IL-9 antibody treatment reduced the proportion of Th17 cells and inhibited STAT3 phosphorylation (43). Here, IL9 is linked to rheumatoid arthritis.